Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others. ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic r...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 2019-05, Vol.37 (14), p.1228-1263 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1263 |
|---|---|
| container_issue | 14 |
| container_start_page | 1228 |
| container_title | Journal of clinical oncology |
| container_volume | 37 |
| creator | Mikhael, Joseph Ismaila, Nofisat Cheung, Matthew C Costello, Caitlin Dhodapkar, Madhav V Kumar, Shaji Lacy, Martha Lipe, Brea Little, Richard F Nikonova, Anna Omel, James Peswani, Namrata Prica, Anca Raje, Noopur Seth, Rahul Vesole, David H Walker, Irwin Whitley, Alexander Wildes, Tanya M Wong, Sandy W Martin, Tom |
| description | To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others.
ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and some phase II studies published from 2005 through 2018. Outcomes of interest included survival, progression-free survival, response rate, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.
The literature search identified 124 relevant studies to inform the evidence base for this guideline.
Evidence-based recommendations were developed for patients with multiple myeloma who are transplantation eligible and those who are ineligible and for patients with relapsed or refractory disease. |
| doi_str_mv | 10.1200/JCO.18.02096 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2201717514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2201717514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-c459328d075635181a2836115424c10e732a42f0c38ea2f228386bbe969441183</originalsourceid><addsrcrecordid>eNo9kL1PwzAQxS0EoqWwMSOPDKT4_BE7bFUEhapVkSgSm-U6jhTkJCVOhv73GFqYnnTvp3d3D6FrIFOghNwv8vUU1JRQkqUnaAyCykRKIU7RmEhGE1DsY4QuQvgkBLhi4hyNGMkYjeYYrTadM33tmh63JV4Nvq923uHV3vm2Ng949pavsWkKnEddtFXkcl81lTUev3bG9pV1eD5UhYtTd4nOSuODuzrqBL0_PW7y52S5nr_ks2VimZB9YrmI-1VBpEiZAAWGKpYCCE65BeLiZYbTklimnKElja5Kt1uXpRnnEB-aoNtD7q5rvwYXel1XwTrvTePaIWhKCUiQAnhE7w6o7doQOlfqXVfVpttrIPqnQB0L1KD0b4ERvzkmD9vaFf_wX2PsG15wZ2k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2201717514</pqid></control><display><type>article</type><title>Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Mikhael, Joseph ; Ismaila, Nofisat ; Cheung, Matthew C ; Costello, Caitlin ; Dhodapkar, Madhav V ; Kumar, Shaji ; Lacy, Martha ; Lipe, Brea ; Little, Richard F ; Nikonova, Anna ; Omel, James ; Peswani, Namrata ; Prica, Anca ; Raje, Noopur ; Seth, Rahul ; Vesole, David H ; Walker, Irwin ; Whitley, Alexander ; Wildes, Tanya M ; Wong, Sandy W ; Martin, Tom</creator><creatorcontrib>Mikhael, Joseph ; Ismaila, Nofisat ; Cheung, Matthew C ; Costello, Caitlin ; Dhodapkar, Madhav V ; Kumar, Shaji ; Lacy, Martha ; Lipe, Brea ; Little, Richard F ; Nikonova, Anna ; Omel, James ; Peswani, Namrata ; Prica, Anca ; Raje, Noopur ; Seth, Rahul ; Vesole, David H ; Walker, Irwin ; Whitley, Alexander ; Wildes, Tanya M ; Wong, Sandy W ; Martin, Tom</creatorcontrib><description>To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others.
ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and some phase II studies published from 2005 through 2018. Outcomes of interest included survival, progression-free survival, response rate, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.
The literature search identified 124 relevant studies to inform the evidence base for this guideline.
Evidence-based recommendations were developed for patients with multiple myeloma who are transplantation eligible and those who are ineligible and for patients with relapsed or refractory disease.</description><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.18.02096</identifier><identifier>PMID: 30932732</identifier><language>eng</language><publisher>United States</publisher><subject>Clinical Trials, Phase II as Topic ; Humans ; Medical Oncology - methods ; Medical Oncology - standards ; Multiple Myeloma - therapy ; Randomized Controlled Trials as Topic ; Systematic Reviews as Topic</subject><ispartof>Journal of clinical oncology, 2019-05, Vol.37 (14), p.1228-1263</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-c459328d075635181a2836115424c10e732a42f0c38ea2f228386bbe969441183</citedby><cites>FETCH-LOGICAL-c357t-c459328d075635181a2836115424c10e732a42f0c38ea2f228386bbe969441183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3716,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30932732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikhael, Joseph</creatorcontrib><creatorcontrib>Ismaila, Nofisat</creatorcontrib><creatorcontrib>Cheung, Matthew C</creatorcontrib><creatorcontrib>Costello, Caitlin</creatorcontrib><creatorcontrib>Dhodapkar, Madhav V</creatorcontrib><creatorcontrib>Kumar, Shaji</creatorcontrib><creatorcontrib>Lacy, Martha</creatorcontrib><creatorcontrib>Lipe, Brea</creatorcontrib><creatorcontrib>Little, Richard F</creatorcontrib><creatorcontrib>Nikonova, Anna</creatorcontrib><creatorcontrib>Omel, James</creatorcontrib><creatorcontrib>Peswani, Namrata</creatorcontrib><creatorcontrib>Prica, Anca</creatorcontrib><creatorcontrib>Raje, Noopur</creatorcontrib><creatorcontrib>Seth, Rahul</creatorcontrib><creatorcontrib>Vesole, David H</creatorcontrib><creatorcontrib>Walker, Irwin</creatorcontrib><creatorcontrib>Whitley, Alexander</creatorcontrib><creatorcontrib>Wildes, Tanya M</creatorcontrib><creatorcontrib>Wong, Sandy W</creatorcontrib><creatorcontrib>Martin, Tom</creatorcontrib><title>Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><description>To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others.
ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and some phase II studies published from 2005 through 2018. Outcomes of interest included survival, progression-free survival, response rate, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.
The literature search identified 124 relevant studies to inform the evidence base for this guideline.
Evidence-based recommendations were developed for patients with multiple myeloma who are transplantation eligible and those who are ineligible and for patients with relapsed or refractory disease.</description><subject>Clinical Trials, Phase II as Topic</subject><subject>Humans</subject><subject>Medical Oncology - methods</subject><subject>Medical Oncology - standards</subject><subject>Multiple Myeloma - therapy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Systematic Reviews as Topic</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kL1PwzAQxS0EoqWwMSOPDKT4_BE7bFUEhapVkSgSm-U6jhTkJCVOhv73GFqYnnTvp3d3D6FrIFOghNwv8vUU1JRQkqUnaAyCykRKIU7RmEhGE1DsY4QuQvgkBLhi4hyNGMkYjeYYrTadM33tmh63JV4Nvq923uHV3vm2Ng949pavsWkKnEddtFXkcl81lTUev3bG9pV1eD5UhYtTd4nOSuODuzrqBL0_PW7y52S5nr_ks2VimZB9YrmI-1VBpEiZAAWGKpYCCE65BeLiZYbTklimnKElja5Kt1uXpRnnEB-aoNtD7q5rvwYXel1XwTrvTePaIWhKCUiQAnhE7w6o7doQOlfqXVfVpttrIPqnQB0L1KD0b4ERvzkmD9vaFf_wX2PsG15wZ2k</recordid><startdate>20190510</startdate><enddate>20190510</enddate><creator>Mikhael, Joseph</creator><creator>Ismaila, Nofisat</creator><creator>Cheung, Matthew C</creator><creator>Costello, Caitlin</creator><creator>Dhodapkar, Madhav V</creator><creator>Kumar, Shaji</creator><creator>Lacy, Martha</creator><creator>Lipe, Brea</creator><creator>Little, Richard F</creator><creator>Nikonova, Anna</creator><creator>Omel, James</creator><creator>Peswani, Namrata</creator><creator>Prica, Anca</creator><creator>Raje, Noopur</creator><creator>Seth, Rahul</creator><creator>Vesole, David H</creator><creator>Walker, Irwin</creator><creator>Whitley, Alexander</creator><creator>Wildes, Tanya M</creator><creator>Wong, Sandy W</creator><creator>Martin, Tom</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190510</creationdate><title>Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline</title><author>Mikhael, Joseph ; Ismaila, Nofisat ; Cheung, Matthew C ; Costello, Caitlin ; Dhodapkar, Madhav V ; Kumar, Shaji ; Lacy, Martha ; Lipe, Brea ; Little, Richard F ; Nikonova, Anna ; Omel, James ; Peswani, Namrata ; Prica, Anca ; Raje, Noopur ; Seth, Rahul ; Vesole, David H ; Walker, Irwin ; Whitley, Alexander ; Wildes, Tanya M ; Wong, Sandy W ; Martin, Tom</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-c459328d075635181a2836115424c10e732a42f0c38ea2f228386bbe969441183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Clinical Trials, Phase II as Topic</topic><topic>Humans</topic><topic>Medical Oncology - methods</topic><topic>Medical Oncology - standards</topic><topic>Multiple Myeloma - therapy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Systematic Reviews as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikhael, Joseph</creatorcontrib><creatorcontrib>Ismaila, Nofisat</creatorcontrib><creatorcontrib>Cheung, Matthew C</creatorcontrib><creatorcontrib>Costello, Caitlin</creatorcontrib><creatorcontrib>Dhodapkar, Madhav V</creatorcontrib><creatorcontrib>Kumar, Shaji</creatorcontrib><creatorcontrib>Lacy, Martha</creatorcontrib><creatorcontrib>Lipe, Brea</creatorcontrib><creatorcontrib>Little, Richard F</creatorcontrib><creatorcontrib>Nikonova, Anna</creatorcontrib><creatorcontrib>Omel, James</creatorcontrib><creatorcontrib>Peswani, Namrata</creatorcontrib><creatorcontrib>Prica, Anca</creatorcontrib><creatorcontrib>Raje, Noopur</creatorcontrib><creatorcontrib>Seth, Rahul</creatorcontrib><creatorcontrib>Vesole, David H</creatorcontrib><creatorcontrib>Walker, Irwin</creatorcontrib><creatorcontrib>Whitley, Alexander</creatorcontrib><creatorcontrib>Wildes, Tanya M</creatorcontrib><creatorcontrib>Wong, Sandy W</creatorcontrib><creatorcontrib>Martin, Tom</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikhael, Joseph</au><au>Ismaila, Nofisat</au><au>Cheung, Matthew C</au><au>Costello, Caitlin</au><au>Dhodapkar, Madhav V</au><au>Kumar, Shaji</au><au>Lacy, Martha</au><au>Lipe, Brea</au><au>Little, Richard F</au><au>Nikonova, Anna</au><au>Omel, James</au><au>Peswani, Namrata</au><au>Prica, Anca</au><au>Raje, Noopur</au><au>Seth, Rahul</au><au>Vesole, David H</au><au>Walker, Irwin</au><au>Whitley, Alexander</au><au>Wildes, Tanya M</au><au>Wong, Sandy W</au><au>Martin, Tom</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2019-05-10</date><risdate>2019</risdate><volume>37</volume><issue>14</issue><spage>1228</spage><epage>1263</epage><pages>1228-1263</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><abstract>To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others.
ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and some phase II studies published from 2005 through 2018. Outcomes of interest included survival, progression-free survival, response rate, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.
The literature search identified 124 relevant studies to inform the evidence base for this guideline.
Evidence-based recommendations were developed for patients with multiple myeloma who are transplantation eligible and those who are ineligible and for patients with relapsed or refractory disease.</abstract><cop>United States</cop><pmid>30932732</pmid><doi>10.1200/JCO.18.02096</doi><tpages>36</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-183X |
| ispartof | Journal of clinical oncology, 2019-05, Vol.37 (14), p.1228-1263 |
| issn | 0732-183X 1527-7755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2201717514 |
| source | MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Clinical Trials, Phase II as Topic Humans Medical Oncology - methods Medical Oncology - standards Multiple Myeloma - therapy Randomized Controlled Trials as Topic Systematic Reviews as Topic |
| title | Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Multiple%20Myeloma:%20ASCO%20and%20CCO%20Joint%20Clinical%20Practice%20Guideline&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Mikhael,%20Joseph&rft.date=2019-05-10&rft.volume=37&rft.issue=14&rft.spage=1228&rft.epage=1263&rft.pages=1228-1263&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.18.02096&rft_dat=%3Cproquest_cross%3E2201717514%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2201717514&rft_id=info:pmid/30932732&rfr_iscdi=true |